Massachusetts General Hospital's Diagnostic Molecular Pathology Laboratory is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital's Diagnostic Molecular Pathology Laboratory has participated in 1 clinical trials.
Therapeutic areas: Hypertrophic Cardiomyopathy, Hearing Loss, Cancer.
Sponsors: Brigham and Women's Hospital.
Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital's Diagnostic Molecular Pathology Laboratory has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital's Diagnostic Molecular Pathology Laboratory has 1 clinical trials on record. Their work covers Hypertrophic Cardiomyopathy, Hearing Loss, Cancer.
Massachusetts General Hospital's Diagnostic Molecular Pathology Laboratory has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.